APA (7th ed.) Citation

Italiano, A., Nanda, S., Briggs, A., García-Foncillas, J., Lassen, U., Vassal, G., . . . Hyman, D. M. (2020). Larotrectinib versus prior therapies in tropomyosin receptor kinase fusion cancer: An intra-patient comparative analysis. Cancers, 12(11), . https://doi.org/10.3390/cancers12113246

Chicago Style (17th ed.) Citation

Italiano, Antoine, et al. "Larotrectinib Versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-patient Comparative Analysis." Cancers 12, no. 11 (2020). https://doi.org/10.3390/cancers12113246.

MLA (9th ed.) Citation

Italiano, Antoine, et al. "Larotrectinib Versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-patient Comparative Analysis." Cancers, vol. 12, no. 11, 2020, https://doi.org/10.3390/cancers12113246.